Billed as a revolution, VGH now has 1 of only 4 of these machines in the world and only 1 in southern hemisphere.
Cateract surgery being the most common, with 200000 per year in aussy; around 4k per eye, a moderate percentage gain in market share, eg 5%, would net $40-80 million extra in revenue (more than doubling current revenue).
There's a reason PRY healthcare have been buying this stock at mid to high 20 cent range.
I've been accumulating at current share price levels, find it amusing how a bit of fear has made for such an undervalued stock.
- Forums
- ASX - By Stock
- VGH
- laserlenssma
laserlenssma, page-2
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online